German Other Utilities Stock News

Nirrin Technologies’ announcement that Hyaltech, a Carl Zeiss Meditec (XTRA:AFX) subsidiary, has purchased an Atlas system for hyaluronic acid measurement puts fresh attention on how the company is refining manufacturing analytics. See our latest analysis for Carl Zeiss Meditec. The Hyaltech Atlas purchase lands at a time when Carl Zeiss Meditec’s share price has picked up short term momentum, with a 1-month share price return of 9.53% and a 90-day return of 15.70%. However, longer term total...

What the ADIDAS PRO WORK launch means for adidas stock The unveiling of ADIDAS PRO WORK, a safety footwear range created with GLO Brands for workers in logistics, manufacturing and transportation, gives adidas (XTRA:ADS) fresh exposure to the professional workwear and PPE segment. This launch extends adidas beyond traditional sports and lifestyle products into job site footwear that is ESD certified, metal free and tailored to varied working conditions, including dedicated models designed...

Readers hoping to buy Delticom AG ( ETR:DEX ) for its dividend will need to make their move shortly, as the stock is...

Central bank policy shifts, rising geopolitical tensions, and worries over energy supply are reshaping the risk and reward profile of many global stocks. For investors, this mix of policy and political pressure can either support earnings or squeeze margins, depending on how each company is positioned. This article looks at three stocks exposed to those forces, all pulled from a Global Policy and Geopolitical Volatility Impact Stocks screener. One appears better placed to benefit, while two...

Merck KGaA (XTRA:MRK) has moved deeper into precision cardiology, committing a $50 million upfront payment and a build-to-buy structure with Saturnus Bio that targets rare genetic cardiomyopathies lacking approved therapies. See our latest analysis for Merck KGaA. Merck KGaA’s recent cardiology deal lands at a time when momentum in the stock has been picking up, with a 30 day share price return of 8.84% and a 90 day share price return of 32.33%. The 1 year total shareholder return of 33.23%...

Recent conflict in the Middle East, including the closure of key shipping lanes in the Strait of Hormuz, has pushed jet fuel costs sharply higher and put Deutsche Post (XTRA:DHL) and its air heavy DHL Express business in focus. See our latest analysis for Deutsche Post. Against this backdrop, Deutsche Post’s recent moves, including the announced CFO transition and ongoing share buyback, sit alongside a share price of €56.0 with strong momentum. This is reflected in a 90-day share price return...

European manufacturing stocks are being pulled in several directions as Turkish inflation eases, EU US trade hits records, and oil markets adjust to calmer supply conditions. Together, these shifts may change how investors think about companies in Germany, France, and Italy that sit at the heart of machinery and industrial goods production. This article focuses on how those news catalysts could affect selected stocks exposed to these trends, and why some investors might see the current...

Volkswagen stock is trading with a weak 5 year share price track record and a high overall value score, which raises a clear question for investors about whether current pessimism around its restructuring plans has pushed the valuation too far down or not far enough. Volkswagen shares have declined 41.8% over the past 5 years, which signals that long term holders have worn a heavy drawdown that now frames how attractive any apparent discount really is. The planned restructuring, including...

SAP stock has fallen 44.5% over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to their assessed worth. Over the last 12 months, SAP has declined 44.5%, which means a lot of pessimism is already reflected in the share price. Recent moves to accelerate AI product development and deepen cloud partnerships can support long term cash flow expectations. At the same time, execution risk around...

Why Vonovia’s new tender offer matters for stockholders Vonovia (XTRA:VNA) has launched a cash tender offer for six euro bond series maturing between 2027 and 2028, alongside plans to issue new notes. The company aims to reshape its near term debt profile. This refinancing step sits alongside an updated voting rights figure of 848,435,117 following a conditional capital increase. Together, these details provide fresh context on both Vonovia’s funding mix and equity base as you assess the...

In recent weeks, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising nearly 2% as lower oil prices and easing inflation concerns bolstered investor sentiment. In this context of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business, potentially aligning well with investors seeking stability and commitment in uncertain times.

Fresh commentary on the growing fumed silica market, particularly for hydrophobic grades, has put Evonik Industries (XTRA:EVK) in focus as investors consider the potential implications of wider industrial uses for the stock. See our latest analysis for Evonik Industries. Against the backdrop of growing interest in hydrophobic fumed silica, Evonik Industries’ share price has a year to date return of 20.81%, while the 1 year total shareholder return is slightly lower at a decline of 1.19%,...

In late June 2026, Siemens AG entered a partnership with IFS AB to link Siemens’ Digital Twin and automation capabilities with IFS’s asset and service data, aiming to create AI-enabled, closed-loop industrial workflows, while also initiating a €6.00 billion share buyback through 2031 and investing €300.00 million to expand German production and add 700 jobs by 2030. Together, these moves highlight Siemens’ push to fuse industrial AI with real-world asset data while simultaneously using its...

Bayer (XTRA:BAYN) has reorganized its U.S. glyphosate operations into Ruveon LLC, a dedicated unit that will oversee pricing, market approach, production, and logistics as part of the Crop Science Five-Year Framework. See our latest analysis for Bayer. The Ruveon reorganization arrives alongside a sharp swing in sentiment toward Bayer, with a 30 day share price return of 56.48% and a 1 year total shareholder return of 105.42%, suggesting momentum has recently strengthened. If this kind of...

Siemens Energy stock has delivered a very large 3 year return while the valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside and the broader checks and market multiples suggesting the shares are not an obvious bargain. A very large 3 year gain of around 10x puts recent Siemens Energy returns front and center for anyone thinking about what the stock is worth today. Strong order momentum for gas turbines and recent contract wins in...

BASF stock has delivered a 30.2% gain over the past three years, yet current valuation checks suggest the shares now sit closer to “about right” than clearly cheap or expensive. Over the last three years, BASF has returned 30.2%, which puts current buyers in a different position from those who entered before this move. Recent product launches such as SkinNexus Collag3n in personal care and the Melooop based automotive interior concept can support sentiment around future cash flows. However,...

Germany’s regulator BaFin has opened a formal audit into Zalando (XTRA:ZAL) over possible omissions in the 2025 accounts related to the About You acquisition, drawing fresh attention to the stock’s recent share price move. See our latest analysis for Zalando. The BaFin audit lands at a time when Zalando’s 1 month share price return of 13.02% and 3 month share price return of 26.90% point to building short term momentum, even though the 1 year total shareholder return declined 5.76% and the 5...

Evotec (XTRA:EVT) is back in focus after Just – Evotec Biologics rolled out J.TRAIN, a turnkey platform that lets biopharmaceutical companies install its continuous biologics manufacturing technology directly inside their own facilities. See our latest analysis for Evotec. While J.TRAIN is drawing attention to Evotec's biologics capabilities, the stock price tells a mixed story, with a 1-day share price return of 1.94% and a 90-day share price return of 13.15% set against a 1-year total...

Redcare Pharmacy index changes catch investor attention Redcare Pharmacy (XTRA:RDC) has shifted within Germany's equity indices, exiting the MDAX Performance Index on 19 June 2026 and joining the SDAX Total Return Index on 22 June 2026, drawing fresh interest to the stock. See our latest analysis for Redcare Pharmacy. The index reshuffle comes after a sharp rebound in Redcare Pharmacy's share price, with a 30 day share price return of 50.95% and a 90 day share price return of 87.13%. However,...

As Google faces a €4.1b antitrust fine in Europe, attention is shifting to European technology stocks that operate in areas like search, browsers, mobile software and app marketplaces without the same global dominance. For investors, this kind of regulatory pressure can sometimes change the balance of power, opening space for regional competitors or altering how large platforms work with partners and users. This article looks at 3 European Technology Competitors that are directly exposed to...

As the European market navigates a mixed landscape of easing inflation expectations and fluctuating stock performances, investors are increasingly focused on companies with strong insider ownership, which can signal confidence in long-term growth potential. In this context, identifying growth stocks backed by insiders can be a strategic approach for those looking to align with entities that demonstrate resilience and commitment amidst economic uncertainties.

As global markets navigate a landscape marked by mixed performances across major indices, small-cap stocks have emerged as resilient players, with the Russell 2000 Index advancing significantly. Amidst rising inflation and evolving economic indicators, investors are increasingly focused on identifying stocks that offer growth potential and stability in the face of market volatility. In this environment, a good stock is often characterized by strong fundamentals, unique market positioning, and...

The European Medicines Agency committee recently recommended revoking the EU marketing authorisation for TAVNEOS®, affecting Fresenius Medical Care's treatment portfolio for kidney patients across the region. This regulatory setback raises questions about how Fresenius Medical Care will adapt its European therapy offering while continuing to invest in digital kidney care initiatives. We’ll now examine how the potential loss of TAVNEOS® in the EU reshapes Fresenius Medical Care’s longer-term...

Siltronic (XTRA:WAF) has moved into the Germany MDAX Index after exiting the SDAX, a reshuffle that can prompt index tracking funds to adjust positions and potentially influence short term trading volumes. See our latest analysis for Siltronic. Beyond the index reshuffle, Siltronic’s 1 day share price return of 7.3% and 90 day share price return of 64.2% sit alongside a 1 year total shareholder return of 107%. This points to strong recent momentum despite a 30 day share price return that is...